In vitro safety evaluation of dopamine D3R antagonist, R-VK4-116, as a potential medication for the treatment of opioid use disorder is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: HHSN271201700014I
National Institutes of Health
Grant: 1Z01DA000424-08
Novel Dopamine D3 Receptor Ligands
Fields of Study
MeSH Terms
Keywords